SG Americas Securities
PTX

SG Americas Securities’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

SG Americas Securities’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-2,102
Closed -$22K – 3255
2016
Q1 		$22K Buy
+2,102
New +$41.8K ﹤0.01% 2836
2015
Q4 		– Sell
-2,776
Closed -$88K – 3186
2015
Q3 		$88K Buy
+2,776
New +$133K ﹤0.01% 1904
2014
Q2 		– Sell
-1,309
Closed -$70K – 2842
2014
Q1 		$70K Buy
+1,309
New +$43.2K ﹤0.01% 2274

Other funds holding PTX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

SG Americas Securities's PTX Position: Q2 2016 in Review

SG Americas Securities sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q2 2016, closing a stake of 2,102 shares — an estimated $22K sold.

SG Americas Securities first reported a position in PTX in Q1 2014 and held it in 3 quarters. The position peaked at $88K in Q3 2015. 56 funds tracked by Wall St. Rank hold PTX as of Q2 2016.

  • SG Americas Securities reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q2 2016 after selling out during the quarter.
  • SG Americas Securities sold 2,102 Pernix Therapeutics Holdings, Inc. shares in Q2 2016, an estimated $22K.
  • SG Americas Securities first reported a position in Pernix Therapeutics Holdings, Inc. in Q1 2014 and held it in 3 quarters.
  • SG Americas Securities's Pernix Therapeutics Holdings, Inc. position peaked at $88K in Q3 2015.
  • 56 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q2 2016.

Based on SG Americas Securities's 13F filing for Q2 2016, filed 3 Aug 2016.